A national overview of the legislation, regulations and guidelines relevant to partner notification (contact tracing) from Canada’s Provinces, Territories and the Public Health Agency of Canada.
A two-day knowledge exchange forum held in 2013 to begin to prioritize issues, and to assess the knowledge gaps and other knowledge translation needs related to PNA.
A review of evidence examining the effect of partner notification strategies.
An analysis of peer-reviewed published evidence on HIV Partner Notification (PN) with special consideration for its application to the current Canadian context.
This evidence review intends to summarize and synthesize the literature relating to the use of these new technologies. This information can be used to inform public health practices as well as policies and procedures for implementing new technologies for STI partner notification.
A brief overview of the purposes and standards of Partner Notification, including how it’s done, by whom, what the “best” approaches may be, as well as what’s next in the field.
The objectives of this review are to describe the structure of PN (partner notification) for Chlamydia and provide an analysis of key findings concerning effective practice, including the definition and measurement of outcome indicators, results of comparative studies and reviews of PN practice for Chlamydia, factors associated with improved outcomes, challenges in PN and strategies to address them, and key knowledge gaps.
Information sheet discussing challenges facing partner notification when intimate partners are unknown to one another, and the degree to which new technologies (internet, email, texts) may improve the chances of notifying anonymous partners of STI exposure.
Overview of internet partner notification (i.e., through websites, internet forums, blogs, social media, email and texts), as a means for patients and public health practitioners to reach out to anonymous partners. Discusses reported effectiveness of IPN, which populations may be more open to IPN, and quantity and quality of evidence about effectiveness and cost-effectiveness, and where further study is needed.